The findings highlight SHP2’s role as a general inhibitor of NK cell responsiveness, shedding light on its involvement in regulating NK cell functions and potential implications for therapeutic interventions targeting SHP2 to enhance NK cell activity in cancer or viral infections [43]. This evidence concerns the gene PTPN11 and viral infectious disease.